
COMPASS Pathways plc
CMPSHealthcare|Biotechnology|GB
$8.61
+0.80 (+10.24%)
DCF Value
$1.38
Tangible Book / Share
$1.02
Cash / Share
$3.20
Next Earnings Report
Mar 4, 2027
EPS est. -$0.40
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Aug 5, 2026 (S-3ASR). Possible dilution.
Upcoming Data Readouts (2)
Jun 2028
Est. completion
P3Major Depressive Disorder
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
NCT06247839n=20
Nov 2028
Est. completion
P2P3PTSD - Post Traumatic Stress Disorder
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
NCT07570654n=300
Awaiting Results (2)
Trials past primary completion date but still active — data readout may be imminent.
Nov 2025
P3
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
NCT05711940Sep 2025
P2
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
NCT05733546Recent Press Releases
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 5, 2026 · Business Wire
Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
Nov 4, 2026 · Business Wire
Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights
Nov 3, 2026 · Business Wire
New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers
Nov 2, 2026 · Business Wire
Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
Oct 28, 2026 · Business Wire
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Oct 27, 2026 · Business Wire
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Oct 14, 2026 · Business Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026 · Business Wire
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Sep 30, 2026 · Business Wire
SEC Filings (62)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Nov 3, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Oct 28, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 5, 2026 | S-3ASR | Shelf registration | DocumentIndex |
| Aug 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 7, 2026 | 8-K | Material event | DocumentIndex |
| May 28, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 15, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 15, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 24, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 24, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 24, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Feb 19, 2026 | 8-K | Material event | DocumentIndex |
| Feb 19, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 17, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 17, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 17, 2026 | 8-K | Material event | DocumentIndex |
| Jan 7, 2026 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 4, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 4, 2025 | 8-K | Material event | DocumentIndex |
| Oct 29, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2025 | 8-K | Material event | DocumentIndex |
| Jul 31, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 29, 2025 | 8-K | Material event | DocumentIndex |
| Jun 23, 2025 | 8-K | Material event | DocumentIndex |
| Jun 13, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 8, 2025 | 8-K | Material event | DocumentIndex |